WallStreetZenWallStreetZen

NASDAQ: CRMD
Cormedix Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CRMD past revenue growth

How has CRMD's revenue growth performed historically?
Company
-67.75%
Industry
104.93%
Market
14.21%
CRMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRMD earnings and revenue history

Current Revenue
$29.7k
Current Earnings
-$39.8M
Current Profit Margin
-133,978%

CRMD Return on Equity

Current Company
-66%
Current Industry
15.9%
Current Market
-9.5%
CRMD's Return on Equity (-66%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRMD announces earnings.

CRMD Return on Assets

Current Company
-59%
Current Industry
2.3%
CRMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRMD Return on Capital Employed

Current Company
-47.47%
Current Industry
17.8%
CRMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRMD$29.70k-$39.68M-$39.79M-43.05%N/A
MRSN$40.84M-$191.71M-$197.05M+26.38%N/A
MACK$0.00-$1.43M-$1.43MN/AN/A
ALVR$0.00-$164.13M-$168.86MN/AN/A
HRTX$122.84M-$115.89M-$119.70M+15.92%N/A
View Top Biotech Stocks

Cormedix Earnings & Revenue FAQ

What were CRMD's earnings last quarter?

On Invalid Date, Cormedix (NASDAQ: CRMD) reported Q3 2023 earnings per share (EPS) of -$0.17, up 0% year over year. Total Cormedix earnings for the quarter were -$9.74 million. In the same quarter last year, Cormedix's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Cormedix stock.

What was CRMD's earnings growth in the past year?

As of Q4 2023, Cormedix's earnings has grown year over year. Cormedix's earnings in the past year totalled -$39.79 million.

What was CRMD's revenue last quarter?

On Invalid Date, Cormedix (NASDAQ: CRMD) reported Q3 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Cormedix's revenue was $6.82 thousand.

What was CRMD's revenue growth in the past year?

As of Q4 2023, Cormedix's revenue has grown -67.75% year over year. This is 172.69 percentage points lower than the US Biotechnology industry revenue growth rate of 104.93%. Cormedix's revenue in the past year totalled $29.70 thousand.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.